West Health Investment Fund Sinks $7.5M into Reflexion Health

Xconomy San Diego — 

The Gary and Mary West Health Investment Fund said it has invested $7.5 million in Reflexion Health, a San Diego startup developing a system that uses Microsoft’s Kinect motion sensing system to help physical therapy patients with their rehab.

Reflexion Health raised $4.25 million in seed funding from the same investment fund when the company moved into the Gary and Mary West Incubator in 2012. The startup’s first product, dubbed Vera, uses the Kinect motion tracking system and a personal computer, and provides interactive feedback and educational information to patients while they are exercising. Pilot studies using the system are underway at the Center for Connected Health, a division of Partners HealthCare in Boston, MA, and at Rady Children’s Hospital in San Diego.

Instead of giving patients photocopied handouts that illustrate their exercise regime, Vera provides instructional video and full-body video game mechanics to patients in their home, using the Microsoft Kinect for Windows. The Web-based system coaches patients through their rehab exercises, monitors their performance, and enables physical therapists and physicians to track a patient’s rehabilitation progress in real time.

In a statement, Kelly Randich, the lead physical therapist at Rady’s Children’s Hospital, says, “We need technologies like Vera to expedite the rehab process by leveraging our highly-skilled therapists to provide more direct patient care, using evidence-based, manual therapy techniques. We are excited to be working with Reflexion Health to help us take better, more efficient care of our patients with orthopedic injuries.”

The funding for Reflexion Health follows a $5 million investment that the Gary and Mary West Health Investment Fund made in Svelte Medical Systems of New Providence, NJ, earlier this month. Svelte said the $5 million is in addition to $22 million in recently raised capital, and will be used to accelerate the company’s efforts to win regulatory approval for its “all-in-one” coronary stenting system. The company says its technology eliminates the need for conventional guide wires and balloons used in percutaneous transluminal coronary angioplasty, a minimally invasive procedure to open blocked coronary arteries.